(Q47328678)

14 January 2018

title

Early decreases in plasma lipid transfer proteins during weight reduction (English)

1 reference

14 January 2018

author name string

Themistoklis Tzotzas

1

1 reference

14 January 2018

Laure Dumont

2

1 reference

14 January 2018

Athanasios Triantos

3

1 reference

14 January 2018

Michael Karamouzis

4

1 reference

14 January 2018

Theodoros Constantinidis

5

1 reference

14 January 2018

Laurent Lagrost

6

1 reference

14 January 2018

publication date

1 June 2006

1 reference

14 January 2018

published in

Obesity

1 reference

14 January 2018

volume

14

1 reference

14 January 2018

issue

6

1 reference

14 January 2018

page(s)

1038-1045

1 reference

14 January 2018

Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Metabolic complications of obesity. Pathophysiologic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Weight loss and plasma lipids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Role of CETP inhibitors in the treatment of dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Updated review on the benefits of weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Increased serum cholesteryl ester transfer protein in obese children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Increased plasma cholesteryl ester transfer activity in obese children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Effects of weight loss on PLTP activity and HDL particle size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.119

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.119

1 reference

14 January 2018

PubMed ID

16861609

1 reference

14 January 2018